These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4226702)

  • 1. Schizophrenic behavior and urinary tryptophan metabolites associated with cysteine given with and without a monoamine oxidase inhibitor (tranylcypromine).
    Spaide J; Tanimukai H; Ginther R; Bueno J; Himwich HE
    Life Sci; 1967 Mar; 6(5):551-60. PubMed ID: 4226702
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative behavioral and biochemical effects of tranylcypromine and cysteine on normal controls and schizophrenic patients.
    Narasimhachari N; Heller B; Spaide J; Haskovec L; Fujimori M; Tabushi K; Himwich HE
    Life Sci I; 1970 Sep; 9(18):1021-32. PubMed ID: 5478406
    [No Abstract]   [Full Text] [Related]  

  • 3. Urinary studies of schizophrenics and controls.
    Narasimhachari N; Heller B; Spaide J; Haskovec L; Fujimori M; Tabushi K; Himwich HE
    Biol Psychiatry; 1971; 3(1):9-20. PubMed ID: 4398666
    [No Abstract]   [Full Text] [Related]  

  • 4. Methionine and tryptophan loading in schizophrenic patients receiving a MAO inhibitor: correlation of behavioral and biochemical changes.
    Spaide J; Neveln L; Tolentino J; Himwich HE
    Biol Psychiatry; 1969 Jul; 1(3):227-33. PubMed ID: 5352654
    [No Abstract]   [Full Text] [Related]  

  • 5. Detection of psychotomimetic N,N-dimethylated indoleamines in the urine of four schizophrenic patients.
    Tanimukai H; Ginther R; Spaide J; Bueno JR; Himwich HE
    Br J Psychiatry; 1970 Oct; 117(539):421-30. PubMed ID: 5312352
    [No Abstract]   [Full Text] [Related]  

  • 6. Biochemical correlates of behavior in schizophrenic patients. Schizophrenic patients receiving tryptophan and methionine or methionine together with a monoamine oxidase inhibitor.
    Berlet HH; Matsumoto K; Pscheidt GR; Spaide J; Bull C; Himwich HE
    Arch Gen Psychiatry; 1965 Dec; 13(6):521-31. PubMed ID: 5841751
    [No Abstract]   [Full Text] [Related]  

  • 7. Occurrence of bufotenin (5-hydroxy-N,N-dimethyltryptamine) in urine of schizophrenic patients.
    Tanimukai H; Ginther R; Spaide J; Bueno JR; Himwich HE
    Life Sci; 1967 Aug; 6(16):1697-706. PubMed ID: 6057885
    [No Abstract]   [Full Text] [Related]  

  • 8. Excretion of catecholamines and tryptophan derivatives in schizophrenia.
    Mileikovskii YA
    Neurosci Behav Physiol; 1979; 9(4):325-8. PubMed ID: 158714
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of tranylcypromine and L-cysteine on plasma amino acids in controls and schizophrenic patients.
    Davis JM; Spaide JK; Himwich HE
    Am J Clin Nutr; 1972 Mar; 25(3):302-10. PubMed ID: 5011913
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tryptophan metabolism in patients with pellagra].
    Brune GG; Brune RM; Wiskemann A
    Arch Dermatol Forsch; 1970; 240(1):44-54. PubMed ID: 4252305
    [No Abstract]   [Full Text] [Related]  

  • 11. Behavioral and biochemical alterations in schizophrenic patients.
    Spaide J; Tanimukai H; Bueno JR; Himwich HE
    Arch Gen Psychiatry; 1968 Jun; 18(6):658-65. PubMed ID: 5651509
    [No Abstract]   [Full Text] [Related]  

  • 12. Correlations between behavior of schizophrenic patients and the urinary excretions of indoles, catechols and steroids.
    Himwich HE
    Folia Psychiatr Neurol Jpn; 1965; 19(4):326-45. PubMed ID: 5899882
    [No Abstract]   [Full Text] [Related]  

  • 13. Urinary acid metabolites of biogenic amines in schizophrenic patients.
    Domino EF
    Schizophr Bull; 1980; 6(2):238-44. PubMed ID: 6154967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tryptophan-load in progressive scleroderma (author's transl)].
    Kreysel HW; Meyerhoff K; Kimmig J
    Klin Wochenschr; 1976 Sep; 54(18):881-7. PubMed ID: 135125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nickel metabolism in schizophrenia patients].
    Soroka VR; Arsent'ev VIa; Mukhaev MS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972 Jan; 72(1):69-72. PubMed ID: 5020157
    [No Abstract]   [Full Text] [Related]  

  • 16. Indoleamine metabolism in affective disorders: excretion of tryptamine, indoleacetic acid and 5-hydroxy-indoleacetic acid in depressive states.
    McNamee HB; Moody JP; Naylor GJ
    J Psychosom Res; 1972 Feb; 16(1):63-70. PubMed ID: 5058989
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma amino acids in schizophrenic patients with methionine or cysteine loading and a monoamine oxidase inhibitor.
    Spaide JK; Davis JM; Himwich HE
    Am J Clin Nutr; 1971 Sep; 24(9):1053-9. PubMed ID: 5094479
    [No Abstract]   [Full Text] [Related]  

  • 18. Excretion patterns of tryptamine, indoleacetic acid, and 5-hydroxyindoleacetic acid, and their correlation with mental changes in schizophrenic patients under medication with alpha-methyldopa.
    Herkert EE; Keup W
    Psychopharmacologia; 1969; 15(1):48-59. PubMed ID: 5367444
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chromatographic separation of tryptophan metabolites on thin-layer silica gel].
    Kniazev IuA; Marchenko LF; Vakhrusheva LL; Denisov BE
    Lab Delo; 1971; 2():114-7. PubMed ID: 4104384
    [No Abstract]   [Full Text] [Related]  

  • 20. Tryptamine metabolism in depression.
    Coppen A; Shaw DM; Malleson A; Eccleston E; Gundy G
    Br J Psychiatry; 1965 Oct; 111(479):993-8. PubMed ID: 5833611
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.